Literature DB >> 9121402

Castleman's disease of the mesentery in a child: a case of seven years' duration without typical X-ray findings.

A Mäkipernaa1, M Ashorn, P Arajärvi, K M Hiltunen, R Karikoski.   

Abstract

This report describes a 9-year-old boy with intermediate variant type of giant lymph node hyperplasia or Castleman's disease (CD) originating from the mesentery. He had symptoms and signs related to the disease for seven years before the final diagnosis. The patient's general condition remained good, except for periods of fever and abdominal pain. Pallor and slow growth were the only abnormal findings on physical examination during the follow-up. Laboratory measurements showed worsening microcytic anemia, low serum iron level, and low iron stores in bone marrow samples. The erythrocyte sedimentation rate (ESR) increased to 110 mm/h, and the serum levels of C-reactive protein varied between 80 and 120 mg/l. The level of serum albumin was low, 25-28 g/l, and serum immunoglobulin G was somewhat elevated, varying between 17-13 g/l. The radiologic examination of intenstine gave pathological results suggesting a small bowel disease, but no tumor was detected. The abnormal laboratory values and symptoms of the patient resolved completely after surgical removal of the mass.

Entities:  

Mesh:

Year:  1997        PMID: 9121402     DOI: 10.1002/(sici)1096-911x(199705)28:5<362::aid-mpo7>3.0.co;2-f

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  2 in total

1.  Laparoscopy-assisted resection for Mesenteric Castleman's disease: Report of a case.

Authors:  Mitsuhiko Ohta; Manabu Yamamoto; Tetsuzo Tagawa; Eiji Tsujita; Ayumi Matsuyama; Jin Okazaki; Tohru Utsunomiya; Shinichi Tsutsui; Megumu Fujihara; Teruyoshi Ishida
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549

2.  Surgical management of abdominal and retroperitoneal Castleman's disease.

Authors:  Pascal Bucher; Gilles Chassot; Guillaume Zufferey; Frederic Ris; Olivier Huber; Philippe Morel
Journal:  World J Surg Oncol       Date:  2005-06-07       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.